In Reply to Elmali and Yazici

Int J Radiat Oncol Biol Phys. 2023 Mar 1;115(3):810-811. doi: 10.1016/j.ijrobp.2022.10.020.

¹ Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
² Ocular Melanoma Center, Massachusetts Eye and Ear, Boston, Massachusetts; ***Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
³ *Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; *Harvard Medical School, Boston, Massachusetts.
⁴ *Ocular Melanoma Center, Massachusetts Eye and Ear, Boston, Massachusetts; *Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
⁵ **Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; **Harvard Medical School, Boston, Massachusetts.
⁶ **Ocular Melanoma Center, Massachusetts Eye and Ear, Boston, Massachusetts; **Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
⁷ ***Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; ***Harvard Medical School, Boston, Massachusetts.
⁸ ****Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; ****Harvard Medical School, Boston, Massachusetts.

No abstract available

Publication types